Comparison of the effect of chronic treatment of mitragynine and morphine on antinociceptive behaviour and cAMP-PKA RIIβ genes expression in mice

dc.contributor.authorAkhir, Sakinah Mohd
dc.date.accessioned2021-01-31T04:25:05Z
dc.date.available2021-01-31T04:25:05Z
dc.date.issued2018
dc.description.abstractTitle: Comparison of the Effect of Chronic Treatment of Mitragynine and Morphine on Antinociceptive Behaviour and cAMP-PKA RIIβ Genes Expression in Mice Background: Mitragynine is an opioid agonist similar to morphine. Chronic administration of morphine is shown to increase the expression of cAMP-PKA RIIβ responsible for the development of tolerance. There were no previous studies done on the effect of chronic mitragynine administration on cAMP-PKA RIIβ gene expression. Therefore, this study aims to evaluate the development of tolerance in mice chronically treated with morphine and mitragynine, assessed by 1) antinociceptive behavior and 2) cAMP-PKA RIIβ gene expression. Methods: A total of 39 Swiss albino mice were randomized into 3 groups, each of which received daily subcutaneous injection of either mitragynine, morphine or placebo, in escalating dose for 9 days. The development of tolerance was assessed by 1) Antinociceptive behaviour study: Antinociceptive response to thermal noxious stimuli was evaluated daily using hot plate test at 52⁰C (52±2⁰C), 30 minutes after drug administration, until the signs of pain (hind-paw licking, jumping) exhibited. The antinociceptive response was quantified as a percentage of maximal possible effect (%MPE) and reduction in mean %MPE more than 50% was used for assessment of antinociceptive tolerance. 2) Molecular study: The cerebral tissues (thalamus, medulla, PAG) were dissected for sampling in order to determine cAMP-PKA RIIβ gene expression using semiquantitative PCR method. Results: Mitragynine-treated mice did not show tolerance by day 9 when compared to placebo (p<0.01), similar to morphine. However, at molecular level, the cAMP-PKA RIIβ gene expression for morphine was enhanced compared to mitragynine and placebo. Conclusion: Chronic treatment with mitragynine did not show development of tolerance on antinociceptive behavior and cAMP-PKA RIIβ gene expression, same as placebo, whereas morphine showed an increased in expression of cAMP-PKA RIIβ gene despite no behavioural antinociceptive tolerance.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/11095
dc.language.isoenen_US
dc.publisherPusat Pengajian Sains Perubatan, Universiti Sains Malaysiaen_US
dc.subjectAnalgesicsen_US
dc.titleComparison of the effect of chronic treatment of mitragynine and morphine on antinociceptive behaviour and cAMP-PKA RIIβ genes expression in miceen_US
dc.typeThesisen_US
Files
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: